Approaches to selective peptidic inhibitors of factor Xa

Area of Science:

• Biochemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Inhibitors targeting procoagulant enzymes like factor Xa (fXa) and thrombin are vital for managing thrombosis.
• Factor Xa is considered a more ideal target than thrombin due to thrombin's complex roles in coagulation.

Purpose of the Study:

• To investigate the kinetic properties of fXa and design specific inhibitors.
• To evaluate the potential of different peptide designs, including beta-peptides, for selective fXa inhibition.

Main Methods:

• Determined kinetic parameters (kcat, Km) for fXa using fluorescence-quenched substrates.
• Designed and synthesized alpha-peptides, beta-homoarginine peptides, and fluorescence-quenched substrates.
• Performed kinetic and competitive inhibition assays with both fXa and thrombin.

Main Results:

• fXa exhibited low selectivity and poor efficiency compared to thrombin.
• Fluorescence-quenched substrates were potent inhibitors of both enzymes.
• Peptides containing beta-amino acids demonstrated enhanced inhibition of fXa compared to alpha-peptides, improving selectivity.

Conclusions:

• Km values may be better indicators than kcat/Km for designing peptidic inhibitors.
• Beta-peptides, especially those with beta-homoarginine, offer a promising strategy for developing selective fXa inhibitors.
• This research provides insights into designing targeted anticoagulants for thrombosis treatment.